51 related articles for article (PubMed ID: 21311105)
1. Inhibition of lytic reactivation of Kaposi's sarcoma-associated herpesvirus by alloferon.
Lee N; Bae S; Kim H; Kong JM; Kim HR; Cho BJ; Kim SJ; Seok SH; Hwang YI; Kim S; Kang JS; Lee WJ
Antivir Ther; 2011; 16(1):17-26. PubMed ID: 21311105
[TBL] [Abstract][Full Text] [Related]
2. Notch signal transduction induces a novel profile of Kaposi's sarcoma-associated herpesvirus gene expression.
Chang H
J Microbiol; 2006 Apr; 44(2):217-25. PubMed ID: 16728959
[TBL] [Abstract][Full Text] [Related]
3. Activation of latent Kaposi's sarcoma-associated herpesvirus by demethylation of the promoter of the lytic transactivator.
Chen J; Ueda K; Sakakibara S; Okuno T; Parravicini C; Corbellino M; Yamanishi K
Proc Natl Acad Sci U S A; 2001 Mar; 98(7):4119-24. PubMed ID: 11274437
[TBL] [Abstract][Full Text] [Related]
4. The contribution of systems biology and reverse genetics to the understanding of Kaposi's sarcoma-associated herpesvirus pathogenesis in endothelial cells.
Stürzl M; Konrad A; Alkharsah KR; Jochmann R; Thurau M; Marquardt G; Schulz TF
Thromb Haemost; 2009 Dec; 102(6):1117-34. PubMed ID: 19967142
[TBL] [Abstract][Full Text] [Related]
5. Immunoreceptor tyrosine-based activation motif-dependent signaling by Kaposi's sarcoma-associated herpesvirus K1 protein: effects on lytic viral replication.
Lagunoff M; Lukac DM; Ganem D
J Virol; 2001 Jul; 75(13):5891-8. PubMed ID: 11390590
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of the promoter region of Kaposi's sarcoma-associated herpesvirus ORF11.
Chen L; Park MS
Virus Res; 2009 Jun; 142(1-2):160-8. PubMed ID: 19428749
[TBL] [Abstract][Full Text] [Related]
7. Lytic cycle switches of oncogenic human gammaherpesviruses.
Miller G; El-Guindy A; Countryman J; Ye J; Gradoville L
Adv Cancer Res; 2007; 97():81-109. PubMed ID: 17419942
[TBL] [Abstract][Full Text] [Related]
8. Anti-HIV agent MAP30 modulates the expression profile of viral and cellular genes for proliferation and apoptosis in AIDS-related lymphoma cells infected with Kaposi's sarcoma-associated virus.
Sun Y; Huang PL; Li JJ; Huang YQ; Zhang L; Huang PL; Lee-Huang S
Biochem Biophys Res Commun; 2001 Oct; 287(4):983-94. PubMed ID: 11573962
[TBL] [Abstract][Full Text] [Related]
9. Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays.
Jenner RG; Albà MM; Boshoff C; Kellam P
J Virol; 2001 Jan; 75(2):891-902. PubMed ID: 11134302
[TBL] [Abstract][Full Text] [Related]
10. Changes occurring on the cell surface during KSHV reactivation.
Whitman AG; Dyson OF; Lambert PJ; Oxendine TL; Ford PW; Akula SM
J Electron Microsc (Tokyo); 2007 Jan; 56(1):27-36. PubMed ID: 17392397
[TBL] [Abstract][Full Text] [Related]
11. Viral IL-6-induced cell proliferation and immune evasion of interferon activity.
Chatterjee M; Osborne J; Bestetti G; Chang Y; Moore PS
Science; 2002 Nov; 298(5597):1432-5. PubMed ID: 12434062
[TBL] [Abstract][Full Text] [Related]
12. Evasion and subversion of interferon-mediated antiviral immunity by Kaposi's sarcoma-associated herpesvirus: an overview.
Sathish N; Yuan Y
J Virol; 2011 Nov; 85(21):10934-44. PubMed ID: 21775463
[TBL] [Abstract][Full Text] [Related]
13. Immune evasion strategies of Kaposi's sarcoma-associated herpesvirus.
Means RE; Choi JK; Nakamura H; Chung YH; Ishido S; Jung JU
Curr Top Microbiol Immunol; 2002; 269():187-201. PubMed ID: 12224509
[TBL] [Abstract][Full Text] [Related]
14. Regulation of CD1d expression and function by a herpesvirus infection.
Sanchez DJ; Gumperz JE; Ganem D
J Clin Invest; 2005 May; 115(5):1369-78. PubMed ID: 15864354
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor activity of immunomodulatory peptide alloferon-1 in mouse tumor transplantation model.
Chernysh S; Irina K; Irina A
Int Immunopharmacol; 2012 Jan; 12(1):312-4. PubMed ID: 22051974
[TBL] [Abstract][Full Text] [Related]
16. Control of Kaposi's sarcoma-associated herpesvirus reactivation induced by multiple signals.
Yu F; Al-Shyoukh I; Feng J; Li X; Liao CW; Ho CM; Shamma JS; Sun R
PLoS One; 2011; 6(6):e20998. PubMed ID: 21904595
[TBL] [Abstract][Full Text] [Related]
17. Study of alloferon, a novel immunomodulatory antimicrobial peptide (AMP), and its analogues.
Appiah C; Chen S; Pori AI; Retyunskiy V; Tzeng C; Zhao Y
Front Pharmacol; 2024; 15():1359261. PubMed ID: 38434708
[TBL] [Abstract][Full Text] [Related]
18. The effect of alloferon on the enhancement of NK cell cytotoxicity against cancer via the up-regulation of perforin/granzyme B secretion.
Bae S; Oh K; Kim H; Kim Y; Kim HR; Hwang YI; Lee DS; Kang JS; Lee WJ
Immunobiology; 2013 Aug; 218(8):1026-33. PubMed ID: 23434435
[TBL] [Abstract][Full Text] [Related]
19. The anti-inflammatory effect of alloferon on UVB-induced skin inflammation through the down-regulation of pro-inflammatory cytokines.
Kim Y; Lee SK; Bae S; Kim H; Park Y; Chu NK; Kim SG; Kim HR; Hwang YI; Kang JS; Lee WJ
Immunol Lett; 2013 Jan; 149(1-2):110-8. PubMed ID: 23018032
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
